Common Contracts
6 similar Operating Agreement contracts
OPERATING AGREEMENT OFOperating Agreement • April 14th, 2021 • Delaware
This Operating Agreement (this “Agreement”) of Mammoth Private Capital, LLC, a Delaware series limited liability company (the “Company”), effective as of the 9th day of February, 2021 (“Effective Date”), is by and among Mammoth Scientific, LLC, a Delaware limited liability company (the “Manager”), and the other Persons who are and shall become members of the Company with respect to a Series in accordance with the provisions hereof (each, a “Member” and, collectively, the “Members”).
EXHIBIT A Operating Agreement of Mammoth Private Capital, LLCOperating Agreement • April 13th, 2021 • Delaware
This Series Designation (the “Series 1 Designation”) of Mammoth Private Capital, LLC, a Delaware limited liability company (the “Company”), is entered into as of February 22, 2021, by and among Mammoth Private Capital, LLC – Health and Tech Fund Series 1 (d/b/a Mammoth Health and Tech Fund 1 – Accredited) (“Series 1”), Mammoth Scientific, LLC, a Delaware limited liability company, as the manager of the Company and Series 1 (the “Manager”), and the undersigned, each of whom shall become a member of the Company with respect to Series 1 (each, a “Member” and, collectively, the “Members”). Capitalized terms used herein and not otherwise defined are used as defined in that certain Limited Liability Company Agreement of the Company, dated as of February 9, 2021 (as may be amended, restated, supplemented or otherwise modified from time to time, the “Agreement”). Any terms of the Agreement not varied herein shall remain in full force and effect. This Series 1 Designation and its terms shall no
EXHIBIT A Operating Agreement of Mammoth Private Capital, LLCOperating Agreement • April 13th, 2021 • Delaware
This Series Designation (the “Series 2 Designation”) of Mammoth Private Capital, LLC, a Delaware limited liability company (the “Company”), is entered into as of February 22, 2021, by and among Mammoth Private Capital, LLC – Health and Tech Fund Series 2 (d/b/a Mammoth Health and Tech Fund 1 – Qualified) (“Series 2”), Mammoth Scientific, LLC, a Delaware limited liability company, as the manager of the Company and Series 2 (the “Manager”), and the undersigned, each of whom shall become a member of the Company with respect to Series 2 (each, a “Member” and, collectively, the “Members”). Capitalized terms used herein and not otherwise defined are used as defined in that certain Limited Liability Company Agreement of the Company, dated as of February 9, 2021 (as may be amended, restated, supplemented or otherwise modified from time to time, the “Agreement”). Any terms of the Agreement not varied herein shall remain in full force and effect. This Series 2 Designation and its terms shall not
EXHIBIT A Operating Agreement of Mammoth Private Capital, LLCOperating Agreement • April 13th, 2021 • Delaware
This Series Designation (the “Series 2 Designation”) of Mammoth Private Capital, LLC, a Delaware limited liability company (the “Company”), is entered into as of February 22, 2021, by and among Mammoth Private Capital, LLC – Health and Tech Fund Series 2 (d/b/a Mammoth Health and Tech Fund 1 – Qualified) (“Series 2”), Mammoth Scientific, LLC, a Delaware limited liability company, as the manager of the Company and Series 2 (the “Manager”), and the undersigned, each of whom shall become a member of the Company with respect to Series 2 (each, a “Member” and, collectively, the “Members”). Capitalized terms used herein and not otherwise defined are used as defined in that certain Limited Liability Company Agreement of the Company, dated as of February 9, 2021 (as may be amended, restated, supplemented or otherwise modified from time to time, the “Agreement”). Any terms of the Agreement not varied herein shall remain in full force and effect. This Series 2 Designation and its terms shall not
EXHIBIT A Operating Agreement of Mammoth Private Capital, LLCOperating Agreement • April 13th, 2021 • Delaware
This Series Designation (the “Series 2 Designation”) of Mammoth Private Capital, LLC, a Delaware limited liability company (the “Company”), is entered into as of February 22, 2021, by and among Mammoth Private Capital, LLC – Health and Tech Fund Series 2 (d/b/a Mammoth Health and Tech Fund 1 – Qualified) (“Series 2”), Mammoth Scientific, LLC, a Delaware limited liability company, as the manager of the Company and Series 2 (the “Manager”), and the undersigned, each of whom shall become a member of the Company with respect to Series 2 (each, a “Member” and, collectively, the “Members”). Capitalized terms used herein and not otherwise defined are used as defined in that certain Limited Liability Company Agreement of the Company, dated as of February 9, 2021 (as may be amended, restated, supplemented or otherwise modified from time to time, the “Agreement”). Any terms of the Agreement not varied herein shall remain in full force and effect. This Series 2 Designation and its terms shall not
EXHIBIT A Operating Agreement of Mammoth Private Capital, LLCOperating Agreement • April 13th, 2021 • Delaware
This Series Designation (the “Series 1 Designation”) of Mammoth Private Capital, LLC, a Delaware limited liability company (the “Company”), is entered into as of February 22, 2021, by and among Mammoth Private Capital, LLC – Health and Tech Fund Series 1 (d/b/a Mammoth Health and Tech Fund 1 – Accredited) (“Series 1”), Mammoth Scientific, LLC, a Delaware limited liability company, as the manager of the Company and Series 1 (the “Manager”), and the undersigned, each of whom shall become a member of the Company with respect to Series 1 (each, a “Member” and, collectively, the “Members”). Capitalized terms used herein and not otherwise defined are used as defined in that certain Limited Liability Company Agreement of the Company, dated as of February 9, 2021 (as may be amended, restated, supplemented or otherwise modified from time to time, the “Agreement”). Any terms of the Agreement not varied herein shall remain in full force and effect. This Series 1 Designation and its terms shall no
